Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
Six patients with mycosis fungoides were treated with topical mechlorethamine hydrochloride for periods of two to four years. Clinical and histological studies for radiomimetic and radiodermatitis-like effects failed to demonstrate any abnormalities. The only observed changes were generalized hyperpigmentation of the skin and melanin-containing melanophages in the papillary dermis. We consider that the long-term use of topical mechlorethamine may be a safe form of therapy, but that a continuous indefinite follow-up of patients on this medication should be mandatory.
D000287:Administration, Topical; D001706:Biopsy; D004247:DNA; D003877:Dermatitis, Contact / Q000209:etiology; D006801:Humans; D008466:Mechlorethamine / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009182:Mycosis Fungoides / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000139:chemically induced; D012867:Skin / Q000187:drug effects / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy*; D012880:Skin Pigmentation / Q000187:drug effects
D008466:Mechlorethamine; D004247:DNA